0001209191-23-018550.txt : 20230314 0001209191-23-018550.hdr.sgml : 20230314 20230314171910 ACCESSION NUMBER: 0001209191-23-018550 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230310 FILED AS OF DATE: 20230314 DATE AS OF CHANGE: 20230314 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kelly James Patrick CENTRAL INDEX KEY: 0001506314 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26770 FILM NUMBER: 23732038 MAIL ADDRESS: STREET 1: C/O SUPERNUS PHARMACEUTICALS, INC. STREET 2: 9715 KEY WEST AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NOVAVAX INC CENTRAL INDEX KEY: 0001000694 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222816046 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21 FIRSTFIELD ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 240-268-2000 MAIL ADDRESS: STREET 1: 21 FIRSTFIELD ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-03-10 0 0001000694 NOVAVAX INC NVAX 0001506314 Kelly James Patrick C/O NOVAVAX, INC. 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878 0 1 0 0 EVP, CFO and Treasurer Common Stock 2023-03-10 4 M 0 4609 6.52 A 5832 D Common Stock 2023-03-10 4 F 0 2471 6.52 D 3361 D Restricted Stock Units 2023-03-10 4 M 0 4609 0.00 D Common Stock 4609 9216 D The shares were received by the reporting person in connection with vesting of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the March 10, 2022 grant date, in each case subject to continued employment through such vesting date. /s/ John A. Herrmann III, Attorney-in-Fact 2023-03-14